Last updated: February 13, 2024
Sponsor: University Children's Hospital, Zurich
Overall Status: Active - Recruiting
Phase
N/A
Condition
Epilepsy (Pediatric)
Epilepsy
Treatment
point of care EEG
Clinical Study ID
NCT05418634
2022-00842
Ages < 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: General: PED:
- Pediatric patients with unexplained impaired consciousness, suspicion of NCSE, activeSE presenting to the PED
- Informed consent of patient of parents/persons responsible, if possible, otherwiseemergency situation procedure (according to national regulations for research inemergency situations) CLINIC:
- Informed consent as documented by signature
- Pediatric patients undergoing cEEG in the outpatient epilepsy clinics
- Either suspected/ to rule out epilepsy or established diagnosis of epilepsy
Exclusion
Exclusion Criteria: PED:
- AMS of known etiology or another diagnosis
- Declined informed consent CLINIC:
- Failure to provide signed informed consent
- Changes in health condition which might interfere with the EEG recording.
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: point of care EEG
Phase:
Study Start date:
August 24, 2022
Estimated Completion Date:
September 01, 2025
Study Description
Connect with a study center
University Children's Hospital Zurich
Zürich, 8032
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.